Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2024(Status and Outlook)
Report Overview:
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
The Global Onychomycosis (Tinea Unguium) Drug Market Size was estimated at USD 3502.22 million in 2023 and is projected to reach USD 4911.99 million by 2029, exhibiting a CAGR of 5.80% during the forecast period.
This report provides a deep insight into the global Onychomycosis (Tinea Unguium) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Onychomycosis (Tinea Unguium) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Onychomycosis (Tinea Unguium) Drug market in any manner.
Global Onychomycosis (Tinea Unguium) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market Segmentation (by Type)
Oral Medication
External Medicine
Market Segmentation (by Application)
Age under 18
Age 18-50
Age above 50
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Onychomycosis (Tinea Unguium) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
The Global Onychomycosis (Tinea Unguium) Drug Market Size was estimated at USD 3502.22 million in 2023 and is projected to reach USD 4911.99 million by 2029, exhibiting a CAGR of 5.80% during the forecast period.
This report provides a deep insight into the global Onychomycosis (Tinea Unguium) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Onychomycosis (Tinea Unguium) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Onychomycosis (Tinea Unguium) Drug market in any manner.
Global Onychomycosis (Tinea Unguium) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market Segmentation (by Type)
Oral Medication
External Medicine
Market Segmentation (by Application)
Age under 18
Age 18-50
Age above 50
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Onychomycosis (Tinea Unguium) Drug Market
- Overview of the regional outlook of the Onychomycosis (Tinea Unguium) Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Onychomycosis (Tinea Unguium) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Key Market Segments
1.2.1 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.2 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2019-2024)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Onychomycosis (Tinea Unguium) Drug Sales Sites, Area Served, Product Type
3.6 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
3.6.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2019-2024)
6.3 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2019-2024)
7 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Onychomycosis (Tinea Unguium) Drug Market Sales by Application (2019-2024)
7.3 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
8 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information
9.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
9.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Yangtze River
9.2.1 Yangtze River Onychomycosis (Tinea Unguium) Drug Basic Information
9.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
9.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.2.4 Yangtze River Business Overview
9.2.5 Yangtze River Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.2.6 Yangtze River Recent Developments
9.3 Torrent Pharma
9.3.1 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
9.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
9.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.3.5 Torrent Pharma Business Overview
9.3.6 Torrent Pharma Recent Developments
9.4 JandJ
9.4.1 JandJ Onychomycosis (Tinea Unguium) Drug Basic Information
9.4.2 JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
9.4.3 JandJ Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.4.4 JandJ Business Overview
9.4.5 JandJ Recent Developments
9.5 Chengdu Brilliant
9.5.1 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Basic Information
9.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
9.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.5.4 Chengdu Brilliant Business Overview
9.5.5 Chengdu Brilliant Recent Developments
9.6 Novartis
9.6.1 Novartis Onychomycosis (Tinea Unguium) Drug Basic Information
9.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
9.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Qilu Pharmaceutical
9.7.1 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
9.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
9.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.7.4 Qilu Pharmaceutical Business Overview
9.7.5 Qilu Pharmaceutical Recent Developments
9.8 Xiuzheng Pharmaceutical
9.8.1 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
9.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
9.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.8.4 Xiuzheng Pharmaceutical Business Overview
9.8.5 Xiuzheng Pharmaceutical Recent Developments
9.9 Hubei Hengan
9.9.1 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Basic Information
9.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
9.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.9.4 Hubei Hengan Business Overview
9.9.5 Hubei Hengan Recent Developments
9.10 TARO
9.10.1 TARO Onychomycosis (Tinea Unguium) Drug Basic Information
9.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Overview
9.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.10.4 TARO Business Overview
9.10.5 TARO Recent Developments
9.11 Perrigo
9.11.1 Perrigo Onychomycosis (Tinea Unguium) Drug Basic Information
9.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
9.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.11.4 Perrigo Business Overview
9.11.5 Perrigo Recent Developments
9.12 Galderma pharm
9.12.1 Galderma pharm Onychomycosis (Tinea Unguium) Drug Basic Information
9.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
9.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.12.4 Galderma pharm Business Overview
9.12.5 Galderma pharm Recent Developments
9.13 Zhejiang Deyer
9.13.1 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Basic Information
9.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
9.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.13.4 Zhejiang Deyer Business Overview
9.13.5 Zhejiang Deyer Recent Developments
9.14 Valeant Pharma
9.14.1 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
9.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
9.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.14.4 Valeant Pharma Business Overview
9.14.5 Valeant Pharma Recent Developments
9.15 Moberg
9.15.1 Moberg Onychomycosis (Tinea Unguium) Drug Basic Information
9.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
9.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.15.4 Moberg Business Overview
9.15.5 Moberg Recent Developments
10 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST BY REGION
10.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast
10.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region
10.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Onychomycosis (Tinea Unguium) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Type (2025-2030)
11.1.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Onychomycosis (Tinea Unguium) Drug by Type (2025-2030)
11.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Key Market Segments
1.2.1 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.2 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2019-2024)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Onychomycosis (Tinea Unguium) Drug Sales Sites, Area Served, Product Type
3.6 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
3.6.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2019-2024)
6.3 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2019-2024)
7 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Onychomycosis (Tinea Unguium) Drug Market Sales by Application (2019-2024)
7.3 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
8 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
8.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information
9.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
9.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Yangtze River
9.2.1 Yangtze River Onychomycosis (Tinea Unguium) Drug Basic Information
9.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
9.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.2.4 Yangtze River Business Overview
9.2.5 Yangtze River Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.2.6 Yangtze River Recent Developments
9.3 Torrent Pharma
9.3.1 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
9.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
9.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug SWOT Analysis
9.3.5 Torrent Pharma Business Overview
9.3.6 Torrent Pharma Recent Developments
9.4 JandJ
9.4.1 JandJ Onychomycosis (Tinea Unguium) Drug Basic Information
9.4.2 JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
9.4.3 JandJ Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.4.4 JandJ Business Overview
9.4.5 JandJ Recent Developments
9.5 Chengdu Brilliant
9.5.1 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Basic Information
9.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
9.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.5.4 Chengdu Brilliant Business Overview
9.5.5 Chengdu Brilliant Recent Developments
9.6 Novartis
9.6.1 Novartis Onychomycosis (Tinea Unguium) Drug Basic Information
9.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
9.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Qilu Pharmaceutical
9.7.1 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
9.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
9.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.7.4 Qilu Pharmaceutical Business Overview
9.7.5 Qilu Pharmaceutical Recent Developments
9.8 Xiuzheng Pharmaceutical
9.8.1 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
9.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
9.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.8.4 Xiuzheng Pharmaceutical Business Overview
9.8.5 Xiuzheng Pharmaceutical Recent Developments
9.9 Hubei Hengan
9.9.1 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Basic Information
9.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
9.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.9.4 Hubei Hengan Business Overview
9.9.5 Hubei Hengan Recent Developments
9.10 TARO
9.10.1 TARO Onychomycosis (Tinea Unguium) Drug Basic Information
9.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Overview
9.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.10.4 TARO Business Overview
9.10.5 TARO Recent Developments
9.11 Perrigo
9.11.1 Perrigo Onychomycosis (Tinea Unguium) Drug Basic Information
9.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
9.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.11.4 Perrigo Business Overview
9.11.5 Perrigo Recent Developments
9.12 Galderma pharm
9.12.1 Galderma pharm Onychomycosis (Tinea Unguium) Drug Basic Information
9.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
9.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.12.4 Galderma pharm Business Overview
9.12.5 Galderma pharm Recent Developments
9.13 Zhejiang Deyer
9.13.1 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Basic Information
9.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
9.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.13.4 Zhejiang Deyer Business Overview
9.13.5 Zhejiang Deyer Recent Developments
9.14 Valeant Pharma
9.14.1 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
9.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
9.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.14.4 Valeant Pharma Business Overview
9.14.5 Valeant Pharma Recent Developments
9.15 Moberg
9.15.1 Moberg Onychomycosis (Tinea Unguium) Drug Basic Information
9.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
9.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product Market Performance
9.15.4 Moberg Business Overview
9.15.5 Moberg Recent Developments
10 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST BY REGION
10.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast
10.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region
10.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Onychomycosis (Tinea Unguium) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Type (2025-2030)
11.1.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Onychomycosis (Tinea Unguium) Drug by Type (2025-2030)
11.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Onychomycosis (Tinea Unguium) Drug Market Size Comparison by Region (M USD)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2022)
Table 10. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Onychomycosis (Tinea Unguium) Drug Sales Sites and Area Served
Table 12. Manufacturers Onychomycosis (Tinea Unguium) Drug Product Type
Table 13. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Onychomycosis (Tinea Unguium) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 22. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (Kilotons)
Table 23. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 24. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2019-2024)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Application
Table 30. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 31. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2024)
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information
Table 44. Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 45. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Yangtze River Onychomycosis (Tinea Unguium) Drug Basic Information
Table 50. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
Table 51. Yangtze River Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Yangtze River Business Overview
Table 53. Yangtze River Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 54. Yangtze River Recent Developments
Table 55. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
Table 56. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 57. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Torrent Pharma Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 59. Torrent Pharma Business Overview
Table 60. Torrent Pharma Recent Developments
Table 61. JandJ Onychomycosis (Tinea Unguium) Drug Basic Information
Table 62. JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
Table 63. JandJ Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. JandJ Business Overview
Table 65. JandJ Recent Developments
Table 66. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Basic Information
Table 67. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
Table 68. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Chengdu Brilliant Business Overview
Table 70. Chengdu Brilliant Recent Developments
Table 71. Novartis Onychomycosis (Tinea Unguium) Drug Basic Information
Table 72. Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
Table 73. Novartis Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
Table 77. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 78. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Qilu Pharmaceutical Business Overview
Table 80. Qilu Pharmaceutical Recent Developments
Table 81. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
Table 82. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 83. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Xiuzheng Pharmaceutical Business Overview
Table 85. Xiuzheng Pharmaceutical Recent Developments
Table 86. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Basic Information
Table 87. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
Table 88. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hubei Hengan Business Overview
Table 90. Hubei Hengan Recent Developments
Table 91. TARO Onychomycosis (Tinea Unguium) Drug Basic Information
Table 92. TARO Onychomycosis (Tinea Unguium) Drug Product Overview
Table 93. TARO Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. TARO Business Overview
Table 95. TARO Recent Developments
Table 96. Perrigo Onychomycosis (Tinea Unguium) Drug Basic Information
Table 97. Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
Table 98. Perrigo Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Perrigo Business Overview
Table 100. Perrigo Recent Developments
Table 101. Galderma pharm Onychomycosis (Tinea Unguium) Drug Basic Information
Table 102. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
Table 103. Galderma pharm Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Galderma pharm Business Overview
Table 105. Galderma pharm Recent Developments
Table 106. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Basic Information
Table 107. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 108. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Zhejiang Deyer Business Overview
Table 110. Zhejiang Deyer Recent Developments
Table 111. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
Table 112. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 113. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Valeant Pharma Business Overview
Table 115. Valeant Pharma Recent Developments
Table 116. Moberg Onychomycosis (Tinea Unguium) Drug Basic Information
Table 117. Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
Table 118. Moberg Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Moberg Business Overview
Table 120. Moberg Recent Developments
Table 121. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Onychomycosis (Tinea Unguium) Drug Market Size Comparison by Region (M USD)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2022)
Table 10. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Onychomycosis (Tinea Unguium) Drug Sales Sites and Area Served
Table 12. Manufacturers Onychomycosis (Tinea Unguium) Drug Product Type
Table 13. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Onychomycosis (Tinea Unguium) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 22. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (Kilotons)
Table 23. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (M USD)
Table 24. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2019-2024)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) by Application
Table 30. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
Table 31. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2024)
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information
Table 44. Pfizer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 45. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Yangtze River Onychomycosis (Tinea Unguium) Drug Basic Information
Table 50. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Overview
Table 51. Yangtze River Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Yangtze River Business Overview
Table 53. Yangtze River Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 54. Yangtze River Recent Developments
Table 55. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
Table 56. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 57. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Torrent Pharma Onychomycosis (Tinea Unguium) Drug SWOT Analysis
Table 59. Torrent Pharma Business Overview
Table 60. Torrent Pharma Recent Developments
Table 61. JandJ Onychomycosis (Tinea Unguium) Drug Basic Information
Table 62. JandJ Onychomycosis (Tinea Unguium) Drug Product Overview
Table 63. JandJ Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. JandJ Business Overview
Table 65. JandJ Recent Developments
Table 66. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Basic Information
Table 67. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Overview
Table 68. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Chengdu Brilliant Business Overview
Table 70. Chengdu Brilliant Recent Developments
Table 71. Novartis Onychomycosis (Tinea Unguium) Drug Basic Information
Table 72. Novartis Onychomycosis (Tinea Unguium) Drug Product Overview
Table 73. Novartis Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
Table 77. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 78. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Qilu Pharmaceutical Business Overview
Table 80. Qilu Pharmaceutical Recent Developments
Table 81. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information
Table 82. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Overview
Table 83. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Xiuzheng Pharmaceutical Business Overview
Table 85. Xiuzheng Pharmaceutical Recent Developments
Table 86. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Basic Information
Table 87. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Overview
Table 88. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hubei Hengan Business Overview
Table 90. Hubei Hengan Recent Developments
Table 91. TARO Onychomycosis (Tinea Unguium) Drug Basic Information
Table 92. TARO Onychomycosis (Tinea Unguium) Drug Product Overview
Table 93. TARO Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. TARO Business Overview
Table 95. TARO Recent Developments
Table 96. Perrigo Onychomycosis (Tinea Unguium) Drug Basic Information
Table 97. Perrigo Onychomycosis (Tinea Unguium) Drug Product Overview
Table 98. Perrigo Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Perrigo Business Overview
Table 100. Perrigo Recent Developments
Table 101. Galderma pharm Onychomycosis (Tinea Unguium) Drug Basic Information
Table 102. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Overview
Table 103. Galderma pharm Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Galderma pharm Business Overview
Table 105. Galderma pharm Recent Developments
Table 106. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Basic Information
Table 107. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Overview
Table 108. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Zhejiang Deyer Business Overview
Table 110. Zhejiang Deyer Recent Developments
Table 111. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information
Table 112. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Overview
Table 113. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Valeant Pharma Business Overview
Table 115. Valeant Pharma Recent Developments
Table 116. Moberg Onychomycosis (Tinea Unguium) Drug Basic Information
Table 117. Moberg Onychomycosis (Tinea Unguium) Drug Product Overview
Table 118. Moberg Onychomycosis (Tinea Unguium) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Moberg Business Overview
Table 120. Moberg Recent Developments
Table 121. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD), 2019-2030
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Onychomycosis (Tinea Unguium) Drug Market Size by Country (M USD)
Figure 11. Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers in 2023
Figure 13. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type
Figure 18. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2023
Figure 20. Market Size Share of Onychomycosis (Tinea Unguium) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application
Figure 24. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2023
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2024)
Figure 27. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2023
Figure 28. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Onychomycosis (Tinea Unguium) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 37. Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2023
Figure 44. China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD), 2019-2030
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Onychomycosis (Tinea Unguium) Drug Market Size by Country (M USD)
Figure 11. Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers in 2023
Figure 13. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type
Figure 18. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2023
Figure 20. Market Size Share of Onychomycosis (Tinea Unguium) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application
Figure 24. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2023
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2024)
Figure 27. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2023
Figure 28. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Onychomycosis (Tinea Unguium) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Onychomycosis (Tinea Unguium) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 37. Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2023
Figure 44. China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2025-2030)
